Systems, methods and devices for producing, manufacturing and control of radiopharmaceuticals
Systems, methods, and devices for generating radionuclides for use in production of radiopharmaceuticals; synthesizing the radionuclides generated and removing any unwanted products; measuring the quantity and activity level of the synthesized radionuclides; distributively delivering the radionuclides in appropriate quantities to modular cassette synthesis units in a modular cassette subsystem for contemporaneous/parallel production of radiopharmaceutical output and that allow reuse and/or quick, safe, and disposable replacement of portions of the subsystem; delivering non-radionuclide components to the modular cassette synthesis units as part of production of radiopharmaceutical output; measuring the quantity and activity level of each stream of radiopharmaceutical output; purifying the radiopharmaceutical output; dispensing individual doses in sterile vial(s); automatically producing labeling and dose related information; performing automated quality control on extracted samples of produced radiopharmaceutical output; and providing software and hardware controls for overall and sub-portion operation for optional remote data collection, communication, and/or control.
1. A radiopharmaceutical production system comprising:
a synthesis unit comprising a module, a cassette, and a reagent pack;
a connection receiving an active product from an active product generator; and
a splitter positioned between the connection and the synthesis unit that divides and routes the active product to the synthesis unit,
wherein the cassette comprises a QMA cartridge, at least one heating provision, a mixing chamber, a neutralizing chamber, a final production collection chamber, and a solid phase exchange cartridge,
wherein the reagent pack comprises a reagent material used to produce at least one radiopharmaceutical, and
wherein the module and reagent pack are both in contact with the cassette.
2. The system according to claim 1 , wherein the splitter comprises:
a vessel for receiving the active product; and
a synthesis unit selector that directs a predetermined amount of the active product to the synthesis unit.
3. The system according to claim 2 , wherein the splitter further comprises a pump positioned between the vessel and the synthesis unit selector, wherein the pump pumps the predetermined amount of active material from the vessel to the synthesis unit selector.
4. The system according to claim 3 , wherein the splitter further comprises:
a prime loop connected between the vessel and the pump;
a line between the pump and the synthesis unit selector;
a rinse fluid line comprising a connection to the pump that enables a rinse fluid to be pumped through at least a portion of the prime loop; and
a gas supply line, wherein the fluid line and the gas supply line comprise a connection to the pump that enables a gas to be pumped through at least the line between the pump and the synthesis unit selector.
5. The system according to claim 4 , wherein the pump comprises a two position pump,
wherein at a first position, the pump:
connects a first portion and a second portion of the prime loop; and
connects the gas supply line to the line between the pump and the synthesis unit selector, and
wherein at a second position, the pump:
disconnects the prime loop,
connects the vessel to the line between the pump and the synthesis unit selector, and
connects the rinse fluid line to the second portion of the prime loop.
6. The system according to claim 1 , wherein the reagent pack is removable from the synthesis component.
7. The system according to claim 1 , further comprising a high performance liquid chromatography (HPLC) unit operatively connected to at least one of the synthesis unit, the connection, or the splitter, wherein the HPLC unit performs purification during production of the radiopharmaceutical.
8. The system according to claim 7 , wherein the HPLC unit comprises a modular HPLC unit having a plurality of columns and a column selector device.
9. The system according to claim 1 , further comprising an automated quality control apparatus for testing of radio-synthesized tracers for at least one selected from a group consisting of particle and color content, filter membrane integrity, pH value, residual solvent volume, Kryptofix concentration, bacterial endotoxins concentration, radionuclidic identity, radionuclidic purity, radiochemical identity, radiochemical purity, and sterility.
10. The system according to claim 9 , wherein the quality control apparatus performs a plurality of tests in parallel.
11. The system according to claim 1 , further comprising an active product generator that includes:
a metering pump and a first check valve to control delivery of a metered amount of a fluid containing 0-18 atoms to a target cell irradiated by a proton beam, wherein the proton beam converts 0-18 to radioactive F-18;
a second check valve coupled to the target cell to control on-demand removal of a portion of the fluid enriched with F-18; and
a gas pressurized switching valve to chase the portion of the fluid enriched with F18 from the system.
12. The system according to claim 11 , wherein the active product generator further comprises:
a reprocessing line that returns unused material from the target cell for reuse; and
an electrochemical component for separating and cleaning the unused material prior to reuse.
13. The system according to claim 1 , further comprising an automated labeling component operatively connected to at least one of the synthesis unit, the connection, or the splitter, wherein the automatic labeling unit labels the radiopharmaceutical.
14. The system according to claim 1 , further comprising a communication connection to a dispensing pharmacy.
15. The system according to claim 1 , further comprising a control component that interfaces with the synthesis unit to manage the production of the radiopharmaceutical.
16. A radiopharmaceutical production system comprising:
a synthesis unit comprising a module, a cassette, and a reagent pack;
a splitter that routes an active product to the synthesis unit;
a purifying component operatively connected to the synthesis unit for purifying a radiopharmaceutical produced by the synthesis unit;
an output measurement component operatively connected to the synthesis unit for measuring at least one of a quantity and a radioactivity of the radiopharmaceutical produced by the synthesis unit;
a vial filler operatively connected to the synthesis unit for dispensing the radiopharmaceutical produced by the synthesis unit into a vial;
a quality control component operatively connected to the synthesis unit for performing automated quality control on a sample of the radiopharmaceutical produced by the synthesis unit; and
a sensor that measures at least one of an activity level of a sample and a volume of the sample, wherein the sensor is comprised in at least one of the splitter, the synthesis unit, the purifying component, the output measurement component, the vial filler, and the quality control component,
wherein the reagent pack comprises a reagent material used to produce the radiopharmaceutical,
wherein the cassette comprises a QMA cartridge, at least one heating provision, a mixing chamber, a neutralizing chamber, a final production collection chamber, and a solid phase exchange cartridge, and
wherein the module and reagent pack are both in contact with the cassette.
17. The system according to claim 14 , wherein the sensor comprises a cadmium zinc telluride (CZT) element.